Waddell & Reed Financial’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-42,960
Closed -$4.52M 494
2019
Q2
$4.52M Hold
42,960
0.01% 441
2019
Q1
$4.54M Sell
42,960
-6,800
-14% -$683K 0.01% 458
2018
Q4
$4.16M Sell
49,760
-11,500
-19% -$1.04M 0.01% 455
2018
Q3
$6.24M Sell
61,260
-22,600
-27% -$2.18M 0.01% 475
2018
Q2
$6.78M Buy
+83,860
New +$6.66M 0.02% 469

Other funds holding NGVT

Waddell & Reed Financial's NGVT Position: Q3 2019 in Review

Waddell & Reed Financial sold out of Ingevity (NGVT) in Q3 2019, closing a stake of 42,960 shares — an estimated $4.52M sold.

Waddell & Reed Financial first reported a position in NGVT in Q2 2018 and held it in 5 quarters. The position peaked at $6.78M in Q2 2018. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • Waddell & Reed Financial reported no remaining Ingevity position as of Q3 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 42,960 Ingevity shares in Q3 2019, an estimated $4.52M.
  • Waddell & Reed Financial first reported a position in Ingevity in Q2 2018 and held it in 5 quarters.
  • Waddell & Reed Financial's Ingevity position peaked at $6.78M in Q2 2018.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on Waddell & Reed Financial's 13F filing for Q3 2019, filed 14 Nov 2019.